Evidence map›Paper›PMID 39891904›Full record

ReviewClinical infectious diseases : an official publication of the Infectious Diseases Society of America2025

What's Hot This Year in Infectious Diseases Clinical Science.

Jeffrey A Freiberg, Patty W Wright

Abstract readReview
In one paragraph

Review in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jeffrey A FreibergDivision of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID 0000-0002-5788-1481
Patty W WrightDivision of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID 0000-0003-4664-6328

Funding

Understanding the role of arginine metabolism in antibiotic treatment failure during Staphylococcus aureus infectionsK08AI185310 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI FREIBERG, JEFFREY ALEXANDER · 2024 to 2024
$186k
National Institute of Allergy and Infectious Diseases, National Institutes of Health K08AI185310NIAID NIH HHS K08 AI185310
6 · The paper itself

Abstract

Clinical science in the field of infectious diseases (ID) moved at a rapid pace in 2024. Among the highlights were multiple trials of new antibiotics and new approaches to prevent infections. Concerning trends, with outbreaks of dengue, measles, mpox, and highly pathogenic avian influenza A in 2024, demonstrate the importance of ID and the continued need for further advances through clinical science. This review highlights some of the most important trials and clinical trends in ID over the past year.

Indexed as

Biomedical ResearchCommunicable DiseasesAnti-Bacterial AgentsClinical Trials as TopicDengueDisease OutbreaksHumansInfluenza, HumanMeaslesAnti-Bacterial Agents

Identifiers

PMID39891904
PMCPMC12272839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.